Frigault, M. J., & Maus, M. V. (2020). State of the art in CAR T cell therapy for CD19(+) B cell malignancies. J Clin Invest.
Chicago Style CitationFrigault, Matthew J., i Marcela V. Maus. "State of the Art in CAR T Cell Therapy for CD19(+) B Cell Malignancies." J Clin Invest 2020.
Cita MLAFrigault, Matthew J., i Marcela V. Maus. "State of the Art in CAR T Cell Therapy for CD19(+) B Cell Malignancies." J Clin Invest 2020.
Atenció: Aquestes cites poden no estar 100% correctes.